[
  {
    "text": "First-line eradication * Vonoprazan 20 mg / Proton pump inhibitor * Amoxicillin hydrate 750 mg * Clarithromycin 200 mg If H",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "20mg"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_1",
    "source_study": "NCT03219723",
    "source_medication": "amoxicillin"
  },
  {
    "text": "Second-line eradication * Vonoprazan 20 mg * Amoxicillin hydrate 750 mg * metronidazole 250 mg This multi-center trial will be conducted in Japan",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "20mg",
      "condition": "Japan"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_2",
    "source_study": "NCT03219723",
    "source_medication": "amoxicillin"
  },
  {
    "text": "vonoprazan fumarate 20 mg/time, 2 times/day, oral Amoxicillin 750mg/ time, 4 times/day, oral, for 10d",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "20mg"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_3",
    "source_study": "NCT05719831",
    "source_medication": "amoxicillin"
  },
  {
    "text": "vonoprazan fumarate 20 mg/time, 2 times/day, oral Amoxicillin1000mg/ time, 2 times/day, oral, for 10d",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "20mg"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_4",
    "source_study": "NCT05719831",
    "source_medication": "amoxicillin"
  },
  {
    "text": "vonoprazan fumarate 20 mg/time, 2 times/day, oral Amoxicillin 750mg/ time, 4 times/day, oral, for 14d",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "20mg"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_5",
    "source_study": "NCT05719831",
    "source_medication": "amoxicillin"
  },
  {
    "text": "This study aimed to evaluate two different amoxicillin dosages (1 g b",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "1g"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_6",
    "source_study": "NCT05719831",
    "source_medication": "amoxicillin"
  },
  {
    "text": "On day 1-14: Standard therapy: esomeprazole magnesium enteric-coated tablets, amoxicillin granules (A Mo Xian), furazolidone tablets, bismuth potassium citrate granules (Li Zhu De Le) are taken twice a day, once in the morning and once in the evening. Esomeprazole magnesium enteric-coated tablets and bismuth potassium citrate granules (Li Zhu De Le) should be taken 30min before meal; amoxicillin granules (A Mo Xian) and furazolidone tablets should be taken 30min after meal. Probiotic: Bifidobacterium tetrad live bacteria tablets should be taken at noon once a day (30 min after meal ), 9 tablets per time. On day 15-28: Probiotic: Bifidobacterium tetrad live bacteria tablets, taken at noon once a day (30min after meal), 9 tablets per time.",
    "expected": {
      "medication": "amoxicillin",
      "condition": "the morning and once in the evening"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_7",
    "source_study": "NCT04034641",
    "source_medication": "amoxicillin"
  },
  {
    "text": "On day 1-14: Standard therapy: esomeprazole magnesium enteric-coated tablets, amoxicillin granules (A Mo Xian), furazolidone tablets, bismuth potassium citrate granules (Li Zhu De Le) are taken twice a day, once in the morning and once in the evening. Esomeprazole magnesium enteric-coated tablets and bismuth potassium citrate granules (Li Zhu De Le) should be taken 30min before meal; amoxicillin granules (A Mo Xian) and furazolidone tablets should be taken 30min after meal. Placebo: Bifidobacterium tetrad live bacteria tablet placebos should be taken at noon once a day ( 30 min after meal ), 9 tablets per time. On day 15-28: Placebo: Bifidobacterium tetrad live bacteria tablet placebos, taken at noon once a day (30min after meal), 9 tablets per time.",
    "expected": {
      "medication": "amoxicillin",
      "condition": "the morning and once in the evening"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_8",
    "source_study": "NCT04034641",
    "source_medication": "amoxicillin"
  },
  {
    "text": "In this group, patients will receive the 10 day sequential regimen for eradication of H. pylori. 10 day sequential regimen is like follows; Esomeprazole 40 mg bid 10 days (D1-D10)+amoxicillin 1 g bid 5 days (D1-D5)+clarithromycin 500 mg bid 5 days (D6-D10)+metronidazole 500 mg tid 5 days (D6-D10).",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "40mg",
      "frequency": "BID",
      "condition": "eradication of H"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_9",
    "source_study": "NCT02373280",
    "source_medication": "amoxicillin"
  },
  {
    "text": "the participants received PPI based triple therapy\\[Esomeprazole 40 mg bid 7 days (D1-D7)+amoxicillin 1000mg bid 7 days (D1-D7)+clarithromycin 500mg bid 7 days (D1-D7)\\]",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "40mg",
      "frequency": "BID"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_10",
    "source_study": "NCT02373280",
    "source_medication": "amoxicillin"
  },
  {
    "text": "moxifloxacin triple therapy \\[Esomeprazole, 40 mg bid 7 days (D1-D7)+Moxifloxacin, 400 mg qd 7 days (D1-D7)+Amoxicillin 1 g bid 7 days (D1-D7)\\].",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "40mg",
      "frequency": "BID"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_11",
    "source_study": "NCT02373280",
    "source_medication": "amoxicillin"
  },
  {
    "text": "bismuth quadruple therapy \\[Esomeprazole, 40 mg bid 7 days (D1-D7)+amoxicillin 1 g bid 7 days (D1-D7)+clarithromycin 500mg bid 7 days (D1-D7)\\], bismuth quadruple therapy \\[Esomeprazole, 40 mg bid 7 days (D1-D7)+Tri potassium dicitrate bismuthate, 300 mg qid 7 days (D1-D7)+Metronidazole, 500 mg tid 7 days (D1-D7)+Tetracycline 500 mg qid 7 days (D1-D7)\\] If there was no metronidazole resistance, the treatment was 7 days in duration. If metronidazole resistance was evident, treatment duration was 14 days.",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "40mg",
      "frequency": "BID",
      "condition": "duration"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_12",
    "source_study": "NCT02373280",
    "source_medication": "amoxicillin"
  },
  {
    "text": "For the eradication of H. pylori, patients diagnosed to be infected with strain with mutation of 23S rRNA, their H. pylori strains are considered to be resistant to clarithromycin. Then, they are treated with vonoprazan 40 mg, metronidazole 500 mg and amoxicillin 1500 mg for 1 week. Patients diagnosed to be infected with strain without mutation of 23S rRNA, their H. pylori strains are considered to be resistant to clarithromycin. Then, they are treated with vonoprazan 40 mg, clarithromycin 400 mg and amoxicillin 1500 mg for 1 week.",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "40mg",
      "condition": "eradication of H"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_13",
    "source_study": "NCT02761005",
    "source_medication": "amoxicillin"
  },
  {
    "text": "pylori and therefore, treated with the triple therapy with vonoprazan 20 mg bid + amoxicillin 750 mg bid + metronidazole 250 mg bid for 1 week",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "20mg",
      "frequency": "BID"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_14",
    "source_study": "NCT02761005",
    "source_medication": "amoxicillin"
  },
  {
    "text": "pylori and therefore, treated with the triple therapy with vonoprazan 20 mg bid + amoxicillin 750 mg bid + clarithromycin 200 mg bid for 1 week",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "20mg",
      "frequency": "BID"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_15",
    "source_study": "NCT02761005",
    "source_medication": "amoxicillin"
  },
  {
    "text": "1 gr/6 hours (4 g x day)",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "1g"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_16",
    "source_study": "NCT05398679",
    "source_medication": "amoxicillin"
  },
  {
    "text": "1 gr/6 hours (4 g x day) Intravenous",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "1g"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_17",
    "source_study": "NCT05398679",
    "source_medication": "amoxicillin"
  },
  {
    "text": "Capsula, 500 mg, t.i.d., 14 days",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "500mg"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_18",
    "source_study": "NCT01368341",
    "source_medication": "amoxicillin"
  },
  {
    "text": "Patients will be randomly allocated into 3 groups: Esomeprazole 20 mg, clarithromycin 500 mg, amoxicillin 1000 mg, and colloidal bismuth pectin 200 mg twice daily for 14 days; Esomeprazole 20 mg, minocycline 100 mg, amoxicillin 1000 mg, and colloidal bismuth pectin 200 mg twice daily for 14 days; Esomeprazole 20 mg, minocycline 100 mg, amoxicillin 1000 mg, and colloidal bismuth pectin 200 mg twice daily for 10 days",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "3g",
      "frequency": "twice daily"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_19",
    "source_study": "NCT04558502",
    "source_medication": "amoxicillin"
  },
  {
    "text": "Amoxicillin 1 g b.i.d. for 2 weeks",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "1g"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_20",
    "source_study": "NCT01667718",
    "source_medication": "amoxicillin"
  },
  {
    "text": "Amoxicillin (po) 500 mg x 3 per day for 3 days.",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "500mg"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_21",
    "source_study": "NCT03273296",
    "source_medication": "amoxicillin"
  },
  {
    "text": "Amoxicillin capsules 500mg and metronidazole tablets 400mg antibiotics were used as an active comparator.",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "500mg"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_22",
    "source_study": "NCT04209777",
    "source_medication": "amoxicillin"
  },
  {
    "text": "High-dose dual therapy (rabeprazole 20 mg qid + amoxicillin 750 mg qid, for 14 days)",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "20mg"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_23",
    "source_study": "NCT03897244",
    "source_medication": "amoxicillin"
  },
  {
    "text": "Bismuth-High-dose dual therapy (rabeprazole 20 mg qid + amoxicillin 750 mg qid + tripotassium dicitrate bismuthate 300 mg qid, for 14 days)",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "20mg"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_24",
    "source_study": "NCT03897244",
    "source_medication": "amoxicillin"
  },
  {
    "text": "Amoxicillin-Metronidazole Bismuth quadruple therapy (rabeprazole 20 mg bid + tripotassium dicitrate bismuthate 600 mg bid + amoxicillin 1000 mg bid + metronidazole 500 mg tid, for 14 days)",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "20mg",
      "frequency": "BID"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_25",
    "source_study": "NCT03897244",
    "source_medication": "amoxicillin"
  },
  {
    "text": "After giving written informed consent, each patient will be randomly allocated, to one of three treatment groups: group A - HDDT (rabeprazole 20 mg qid + amoxicillin 750 mg qid for 14 days); group B - Bis-HDDT (rabeprazole 20 mg qid + amoxicillin 750 mg qid + tripotassium dicitrate bismuthate 300 mg qid, for 14 days); group C - AM-BQT (rabeprazole 20 mg bid + tripotassium dicitrate bismuthate 600 mg bid + amoxicillin 1000 mg bid + metronidazole 500 mg tid , for 14 days); All patients will be asked to complete a questionnaire and to record symptoms, drug consumption, and diet content daily during the treatment period",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "20mg",
      "frequency": "BID"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_26",
    "source_study": "NCT03897244",
    "source_medication": "amoxicillin"
  },
  {
    "text": "Allergy skin testing is done by puncture and intradermal. If all tests negative, subjects receive an oral amoxicillin challenge.",
    "expected": {
      "medication": "amoxicillin",
      "condition": "testing is done by puncture and intradermal"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_27",
    "source_study": "NCT01818336",
    "source_medication": "amoxicillin"
  },
  {
    "text": "Patients will be given amoxicillin 500mg for every 8 hours or clindamycin 300mg for every 8 hours for 7 - 10 days after surgery.\n\nPatients will be given Ibuprofen 600mg every 12 hours for pain relief following surgery at least for first three days as needed.\n\nPatients will be given chlorhexidine 0,12% mouth rinse at least every 8 hours starting 24 hours after surgery for 14 days.",
    "expected": {
      "medication": "amoxicillin",
      "dosage": "500mg",
      "frequency": "every 8 hours"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_28",
    "source_study": "NCT02054676",
    "source_medication": "amoxicillin"
  },
  {
    "text": "During first 48 hours after surgery all patients wil receive paracetamol 15 mg/kg iv every 8 hours and ibuprofen 10 mg/kg orally (or through gastric tube) every 12 hours after surgery.\n\nIn case of severe pain tramadol 0,5 mg/kg will be administered iv every 8 hours.",
    "expected": {
      "medication": "ibuprofen",
      "dosage": "15mg",
      "frequency": "every 8 hours"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_29",
    "source_study": "NCT04294537",
    "source_medication": "ibuprofen"
  },
  {
    "text": "A Single Center, Single Dose, Open Label, Randomized, Two Period, Two Sequence Crossover Study to Evaluate the Relative Bioavailibility of Ibuprofen From a Fixed-dose Combination Tablet Containing Ibuprofen 400 mg and Caffeine 100 mg and a Tablet of Ibuprofen 400 mg in at Least 30 Healthy Males and Females Under Fed Conditions The objective of the trial is to compare to combination of 400 mg ibuprofen and 100 mg caffeine against 400 mg ibuprofen alone under fed conditions",
    "expected": {
      "medication": "ibuprofen",
      "dosage": "400mg"
    },
    "complexity": "clinical_trial",
    "case_id": "trial_30",
    "source_study": "NCT02629354",
    "source_medication": "ibuprofen"
  }
]